A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc(™)) in patients with locally advanced or metastatic cancer

di Greil, Richard, Greil-Ressler, Sigrun, Weiss, Lukas, Schönlieb, Charlotte, Magnes, Teresa, Radl, Bianca, Bolger, Gordon T., Vcelar, Brigitta, Sordillo, Peter P.
Pubblicato in Cancer Chemother Pharmacol (2018)

Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations

di Greil, Richard, Pleyer, Lisa, Jansko, Bettina, Feierabend, Carmen, Rettenbacher, Lukas, Stiefel, Olga, Rass, Christoph, Morre, Patrick, Neureiter, Daniel, Greil-Ressler, Sigrun
Pubblicato in Oncotarget (2018)

Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL‐2 and/or BIM

di Huemer, Florian, Melchardt, Thomas, Jansko, Bettina, Wahida, Adam, Jilg, Stefanie, Jost, Philipp J., Klieser, Eckhard, Steiger, Katja, Magnes, Teresa, Pleyer, Lisa, Greil‐Ressler, Sigrun, Rass, Christof, Greil, Richard, Egle, Alexander
Pubblicato in Eur J Haematol (2019)